<h2 id="mechanism-of-action">Mechanism of Action</h2>
<p>5-HT3 antagonist</p>
<h2 id="indications">Indications</h2>
<p>[[Post-operative Nausea and Vomiting]]
  NNT 6 for postoperative nausea and 7 for postoperative vomiting</p>
<h2 id="dosage">Dosage</h2>
<p>4 mg IV or 8mg PO disolving (50% bioavailable) <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></p>
<h2 id="complications">Complications</h2>
<p>NNH 36 for headache
  NNH 31 for elevated LFTs
  NNH 23 for constipation</p>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <table>
        <tbody>
          <tr>
            <td>[[@ganFourthConsensusGuidelines2020</td>
            <td>Tong J. Gan, Kumar G. Belani, Sergio Bergese, Frances Chung, Pierre Diemunsch, Ashraf S. Habib, Zhaosheng Jin, Anthony L. Kovac, Tricia A. Meyer, Richard D. Urman, Christian C. Apfel, Sabry Ayad, Linda Beagley, Keith Candiotti, Marina Englesakis, Traci L. Hedrick, Peter Kranke, Samuel Lee, Daniel Lipman, Harold S. Minkowitz, John Morton, Beverly K. Philip, Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, 2020]]</td>
          </tr>
        </tbody>
      </table>
      <p><a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>